87
Views
5
CrossRef citations to date
0
Altmetric
Case Report

Efficacy of denosumab therapy for neurofibromatosis type 1 with osteoporosis and history of fractures: a case report

, , , , , , , , & show all
Pages 1243-1246 | Published online: 16 Jul 2018

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Masashi Uehara, Yukio Nakamura, Takako Suzuki, Jun Takahashi & Hiroyuki Kato. (2020) Efficacy of denosumab therapy after alendronate treatment for a 66-year-old woman with Camurati–Engelmann disease and osteoporosis: a case report. Modern Rheumatology Case Reports 4:1, pages 131-134.
Read now

Articles from other publishers (4)

Masashi Uehara, Yukio Nakamura, Takako Suzuki, Noriko Sakai & Jun Takahashi. (2021) Efficacy of denosumab therapy for a 12-year-old female patient with Williams syndrome with osteoporosis and history of fractures: a case report. Journal of Medical Case Reports 15:1.
Crossref
Qian Tan, Jiang‐Yan Wu, Yao‐Xi Liu, Kun Liu, Jin Tang, Wei‐Hua Ye, Guang‐Hui Zhu, Hai‐Bo Mei & Ge Yang. (2020) The neurofibromatosis type I gene promotes autophagy via mTORC1 signalling pathway to enhance new bone formation after fracture. Journal of Cellular and Molecular Medicine 24:19, pages 11524-11534.
Crossref
Stergios A. Polyzos, Polyzois Makras, Symeon Tournis & Athanasios D. Anastasilakis. (2019) Off-label uses of denosumab in metabolic bone diseases. Bone 129, pages 115048.
Crossref
Tsukasa Kobayashi, Yukio Nakamura, Takako Suzuki, Tomomi Yamaguchi, Ryojun Takeda, Masaki Takagi, Tomonobu Hasegawa, Tomoki Kosho & Hiroyuki Kato. (2018) Efficacy and Safety of Denosumab Therapy for Osteogenesis Imperfecta Patients with Osteoporosis—Case Series. Journal of Clinical Medicine 7:12, pages 479.
Crossref